Dr Reddys Laboratories informs about press release

17 Feb 2021 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 17th February 2021 titled ‘Dr. Reddy's Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1217.60 8.40 (0.69%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.65
Dr. Reddys Lab 1217.60
Cipla 1193.40
Zydus Lifesciences 864.25
Lupin 2276.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×